CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Operating activities:
Net income (loss)	$ (734,000)	$ 352,000
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Fair value of common stock issued for services	244,000	0
Fair value of warrants granted for services	0	105,000
Gain on patent assignment	0	(880,000)
Effect of changes in:
Accounts receivable	10,000	0
Prepaid expenses	13,000	7,000
Inventory		(11,000)
Operating lease right of use asset	0	36,000
Accounts payable and accrued expenses	66,000	55,000
Operating lease liability	0	(40,000)
Net cash used in operating activities	(401,000)	(376,000)
Investing activities:
Proceeds from patent assignment	0	880,000
Net cash provided by investing activities	0	880,000
Financing activities:
Proceeds from convertible note payable	10,000	0
Proceeds from common stock units	173,000	0
Repayment of note payable	0	(2,000)
Net cash provided by (used in) financing activities	183,000	(2,000)
Net (decrease) increase in cash and cash equivalents	(218,000)	502,000
Cash and cash equivalents, beginning of period	249,000	179,000
Cash and cash equivalents, end of period	31,000	681,000
Supplemental disclosures of cash flow information:
Cash paid for interest	2,000	1,000
Cash paid for income taxes	0	0
Supplemental disclosures of non-cash transactions:
Conversion feature of convertible note payable accounted as derivative liability	$ 7,000	$ 0